Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients
- PMID: 34781978
- PMCID: PMC8591892
- DOI: 10.1186/s12955-021-01889-4
Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients
Abstract
Background: The adult versions EQ-5D-3L and EQ-5D-5L have been extensive compared. This is not the case for the EQ-5D youth versions. The study aim was to compare the measurement properties and responsiveness of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients.
Methods: A sample of patients 8-16 years old with different diseases and a wide range of disease severity was asked to complete EQ-5D-Y-3L, EQ-5D-Y-5L, PedsQL Generic Core Scale, and selected, appropriate disease-specific instruments, three times. EQ-5D-Y-3L and EQ-5D-Y-5L were compared in terms of: feasibility, (re-)distribution properties, discriminatory power, convergent validity, test-retest reliability, and responsiveness.
Results: 286 participating patients suffered from one of the following diseases: major beta-thalassemia, haemophilia, acute lymphoblastic leukaemia, acute illness. Missing responses were comparable between versions of the EQ-5D-Y, suggesting comparable feasibility. The number of patients in the best health state (level profile 11111) was equal in both EQ-5D-Y versions. The projection of EQ-5D-Y-3L scores onto EQ-5D-Y-5L for all dimensions showed that the two additional levels in EQ-5D-Y-5L slightly improved the accuracy of patients in reporting their problems, especially if severe. Convergent validity with PedsQL and disease-specific measures showed that the two EQ-5D-Y versions performed about equally. Test-retest reliability (EQ-5D-Y-3L 0.78 vs EQ-5D-Y-5L 0.84), and sensitivity for detecting health changes, were both better in EQ-5D-Y-5L.
Conclusions: Extending the number of levels did not give clear superiority to EQ-5D-Y-5L over EQ-5D-Y-3L based on the criteria assessed in this study. However, increasing the number of levels benefitted EQ-5D-Y performance in the measurement of moderate to severe problems and especially in longitudinal study designs.
Keywords: EQ-5D-Y-3L paediatric patients; EQ-5D-Y-5L; Health-related quality of life; Psychometrics.
© 2021. The Author(s).
Conflict of interest statement
TF, RR, RM, and NS report no conflicts of interest. FP, GB, ES, JB are either members of the EuroQol Group or are directly employed by the EuroQol Research Foundation.
Figures
Similar articles
-
EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report.Health Qual Life Outcomes. 2022 Jun 3;20(1):88. doi: 10.1186/s12955-022-01996-w. Health Qual Life Outcomes. 2022. PMID: 35659313 Free PMC article.
-
Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds.Pharmacoeconomics. 2024 Jun;42(Suppl 1):129-145. doi: 10.1007/s40273-024-01350-6. Epub 2024 Jan 18. Pharmacoeconomics. 2024. PMID: 38238604 Free PMC article.
-
Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.Pharmacoeconomics. 2024 Jun;42(Suppl 1):57-77. doi: 10.1007/s40273-024-01354-2. Epub 2024 Feb 8. Pharmacoeconomics. 2024. PMID: 38329689 Free PMC article.
-
Head-to-Head Comparisons of the Distributional Characteristics and Measurement Properties of the 3-Level and 5-Level Versions of the EQ-5D-Y: A Systematic Review.Value Health. 2025 Apr 15:S1098-3015(25)02303-4. doi: 10.1016/j.jval.2025.03.020. Online ahead of print. Value Health. 2025. PMID: 40246069 Review.
-
A Review of the Psychometric Performance of Selected Child and Adolescent Preference-Based Measures Used to Produce Utilities for Child and Adolescent Health.Value Health. 2021 Mar;24(3):443-460. doi: 10.1016/j.jval.2020.09.012. Epub 2020 Nov 7. Value Health. 2021. PMID: 33641779 Review.
Cited by
-
Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers.Eur J Health Econ. 2024 Nov;25(8):1361-1370. doi: 10.1007/s10198-024-01669-z. Epub 2024 Feb 14. Eur J Health Econ. 2024. PMID: 38356007
-
Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi.J Patient Rep Outcomes. 2023 Mar 9;7(1):22. doi: 10.1186/s41687-023-00560-4. J Patient Rep Outcomes. 2023. PMID: 36892714 Free PMC article.
-
Research progress on mechanism of follicle injury after ovarian tissue transplantation and protective strategies.Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Apr 1;53(3):321-330. doi: 10.3724/zdxbyxb-2023-0566. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 38562041 Free PMC article. Review. Chinese, English.
-
Cross-cultural adaptation and content validation of the Singapore English version of EQ-5D-Y: a qualitative study.Health Qual Life Outcomes. 2024 Sep 27;22(1):82. doi: 10.1186/s12955-024-02290-7. Health Qual Life Outcomes. 2024. PMID: 39334361 Free PMC article.
-
EuroQol Toddler and Infant Populations (EQ-TIPS): Age-Related Differences in Performance.Children (Basel). 2024 Aug 22;11(8):1034. doi: 10.3390/children11081034. Children (Basel). 2024. PMID: 39201968 Free PMC article.
References
-
- Brooks R, Group E. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources